← Leaderboards
Jody L Baron
University Of California, San Francisco
$11,851,518
Attributed
$15,464,612
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,464,612 · 8
By mechanism
R01$13,855,339 · 5
P30$985,273 · 1
R56$624,000 · 2
Top collaborators
- Stewart Cooper10 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Nathalie Bzowej$1,604,881
- Christopher David Caballero Allen$8,048,755
- Diane V Havlir$125,216,731
- Nicholas Daniel Carey$94,970
- Limin Liu$1,845,114
Others in their field
Top investigators on “Immune Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,695,345
- Barton F Haynes · Duke University$456,664,915
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$309,708,725
- Peter B. Gilbert · Fred Hutchinson Cancer Center$192,329,665
Research focus
Immune ResponseLiver DiseasesCellsViralLiver BiopsyMouse ModelPrimary Carcinoma Of The Liver CellsResponseLiverHepatitis B VirusChronic Hepatitis BTissuesImmuneHepatitis BCessation Of LifeMediatingBaseLiver FailureHepaticGrantInfectionChronicProductionBiology
Grant awards (32)
Immune analysis of the HBsAg seroclearance response terminating chronic HBV$814,790
R01 · FY2025 · AI · contact PI
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B$723,268
R01 · FY2025 · DK
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B$686,488
R01 · FY2024 · DK
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B$718,565
R01 · FY2023 · DK
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B$727,689
R01 · FY2022 · DK
Immunology & Cell Analysis Core$199,404
P30 · FY2022 · DK · contact PI
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B$762,427
R01 · FY2021 · DK
Identifying and modulating therapeutic targets in a model of hepatitis B$548,297
R01 · FY2021 · AI · contact PI
Immunology & Cell Analysis Core$199,404
P30 · FY2021 · DK · contact PI
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B$682,265
R01 · FY2020 · DK
Identifying and modulating therapeutic targets in a model of hepatitis B$571,983
R01 · FY2020 · AI · contact PI
Immunology & Cell Analysis Core$194,216
P30 · FY2020 · DK · contact PI
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B$699,003
R01 · FY2019 · DK
Identifying and modulating therapeutic targets in a model of hepatitis B$568,736
R01 · FY2019 · AI · contact PI
Immunology & Cell Analysis Core$194,748
P30 · FY2019 · DK · contact PI
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B$707,841
R01 · FY2018 · DK
Identifying and modulating therapeutic targets in a model of hepatitis B$566,743
R01 · FY2018 · AI · contact PI
Immunology & Cell Analysis Core$197,501
P30 · FY2018 · DK · contact PI
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B$723,189
R01 · FY2017 · DK
Identifying and modulating therapeutic targets in a model of hepatitis B$237,750
R56 · FY2017 · DK · contact PI
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B$795,453
R01 · FY2016 · DK
Identifying and modulating therapeutic targets in a model of hepatitis B$344,738
R01 · FY2016 · DK · contact PI
Identifying and modulating therapeutic targets in a model of hepatitis B$344,738
R01 · FY2015 · DK · contact PI
Identifying and modulating therapeutic targets in a model of hepatitis B$343,741
R01 · FY2014 · DK · contact PI
Identifying and modulating therapeutic targets in a model of hepatitis B$329,699
R01 · FY2013 · DK · contact PI
Identifying and modulating therapeutic targets in a model of hepatitis B$340,478
R01 · FY2012 · DK · contact PI
Age-dependent immune responses to hepatitis B: a mouse model of human disease$386,250
R56 · FY2011 · AI · contact PI
Understanding Immunopathogenesis of Hepatitis B Virus$364,245
R01 · FY2010 · AI · contact PI
Understanding Immunopathogenesis of Hepatitis B Virus$367,923
R01 · FY2009 · AI · contact PI
Understanding Immunopathogenesis of Hepatitis B Virus$367,527
R01 · FY2008 · AI · contact PI
Understanding Immunopathogenesis of Hepatitis B Virus$373,430
R01 · FY2007 · AI · contact PI
Understanding Immunopathogenesis of Hepatitis B Virus$382,083
R01 · FY2006 · AI · contact PI